Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b - PubMed (original) (raw)
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
T Seya et al. J Exp Med. 1986.
Abstract
Based on preliminary evidence indicating that a cell-associated protein of U937 (a human monocyte-like cell line) possessed cofactor activity and was not the C3b/C4b receptor, we sought to further characterize this protein. A sequential four-column purification procedure was devised that includes C3(H2O) affinity chromatography to isolate in reasonable yields and purity a cell-associated protein of U937 and several other human cell lines. Based on its pattern and Mr on SDS-PAGE, acidic pI, and ligand specificity, it is identical to a recently described C3(H2O) or C3b-binding membrane glycoprotein of human PBL and cell lines; having no presently identified function, it was termed gp45-70. After purifying this protein, we determined its functional capabilities and compared them to those of the other complement proteins with regulatory activity directed at components comprising the C3 convertases. This protein was the most efficient (50 times that of H) yet-described cofactor for the I-mediated first cleavage of C3b. It also was a cofactor for the first cleavage of C4b, but was not as efficient as C4bp. The second cleavage of C3b and C4b was not efficiently mediated. It had no ability to accelerate decay in the classical or alternative pathway C3 convertases. Based on this unique activity profile and ability to be surface labeled, we have renamed this molecule membrane cofactor protein (MCP). We suggest that this protein plays a major role in preventing autologous complement activation.
Similar articles
- Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, Atkinson JP. Barilla-LaBarca ML, et al. J Immunol. 2002 Jun 15;168(12):6298-304. doi: 10.4049/jimmunol.168.12.6298. J Immunol. 2002. PMID: 12055245 - Functional properties of membrane cofactor protein of complement.
Seya T, Atkinson JP. Seya T, et al. Biochem J. 1989 Dec 1;264(2):581-8. doi: 10.1042/bj2640581. Biochem J. 1989. PMID: 2481448 Free PMC article. - Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF. Fearon DT, et al. Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review. - Membrane cofactor protein.
Liszewski MK, Atkinson JP. Liszewski MK, et al. Curr Top Microbiol Immunol. 1992;178:45-60. doi: 10.1007/978-3-642-77014-2_4. Curr Top Microbiol Immunol. 1992. PMID: 1424776 Review.
Cited by
- Analysis of binding sites on complement factor I using artificial N-linked glycosylation.
Sanchez-Gallego JI, Groeneveld TW, Krentz S, Nilsson SC, Villoutreix BO, Blom AM. Sanchez-Gallego JI, et al. J Biol Chem. 2012 Apr 20;287(17):13572-83. doi: 10.1074/jbc.M111.326298. Epub 2012 Mar 5. J Biol Chem. 2012. PMID: 22393059 Free PMC article. - Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46.
Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K. Mori Y, et al. J Virol. 2002 Jul;76(13):6750-61. doi: 10.1128/jvi.76.13.6750-6761.2002. J Virol. 2002. PMID: 12050388 Free PMC article. - Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.
Seifert PS, Hansson GK. Seifert PS, et al. J Clin Invest. 1989 Aug;84(2):597-604. doi: 10.1172/JCI114204. J Clin Invest. 1989. PMID: 2474572 Free PMC article. - Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.
Minta J, Fung M. Minta J, et al. Mol Cell Biochem. 1999 Nov;201(1-2):111-23. doi: 10.1023/a:1007064602321. Mol Cell Biochem. 1999. PMID: 10630630 - Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells.
Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjørge L, Bützow R, Zipfel PF, Meri S. Junnikkala S, et al. Br J Cancer. 2002 Nov 4;87(10):1119-27. doi: 10.1038/sj.bjc.6600614. Br J Cancer. 2002. PMID: 12402151 Free PMC article.
References
- J Exp Med. 1979 Aug 1;150(2):267-76 - PubMed
- Nature. 1978 Oct 26;275(5682):699-704 - PubMed
- J Immunol. 1980 Aug;125(2):578-82 - PubMed
- J Immunol Methods. 1980;37(2):133-8 - PubMed
- Mol Immunol. 1980 Nov;17(11):1365-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous